184 related articles for article (PubMed ID: 36352097)
1. TNFα-induced IDH1 hyperacetylation reprograms redox homeostasis and promotes the chemotherapeutic sensitivity.
Yang H; Zhao X; Liu J; Jin M; Liu X; Yan J; Yao X; Mao X; Li N; Liang B; Xie W; Zhang K; Zhao J; Liu L; Huang G
Oncogene; 2023 Jan; 42(1):35-48. PubMed ID: 36352097
[TBL] [Abstract][Full Text] [Related]
2. SIRT2-dependent IDH1 deacetylation inhibits colorectal cancer and liver metastases.
Wang B; Ye Y; Yang X; Liu B; Wang Z; Chen S; Jiang K; Zhang W; Jiang H; Mustonen H; Puolakkainen P; Wang S; Luo J; Shen Z
EMBO Rep; 2020 Apr; 21(4):e48183. PubMed ID: 32141187
[TBL] [Abstract][Full Text] [Related]
3. Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-Fluorouracil.
Yang H; Xie S; Liang B; Tang Q; Liu H; Wang D; Huang G
J Cancer; 2021; 12(16):4862-4872. PubMed ID: 34234856
[TBL] [Abstract][Full Text] [Related]
4. Lycorine promotes IDH1 acetylation to induce mitochondrial dynamics imbalance in colorectal cancer cells.
Zhuo FF; Li L; Liu TT; Liang XM; Yang Z; Zheng YZ; Luo QW; Lu JH; Liu D; Zeng KW; Tu PF
Cancer Lett; 2023 Oct; 573():216364. PubMed ID: 37648148
[TBL] [Abstract][Full Text] [Related]
5. Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
Jiang L; Shestov AA; Swain P; Yang C; Parker SJ; Wang QA; Terada LS; Adams ND; McCabe MT; Pietrak B; Schmidt S; Metallo CM; Dranka BP; Schwartz B; DeBerardinis RJ
Nature; 2016 Apr; 532(7598):255-8. PubMed ID: 27049945
[TBL] [Abstract][Full Text] [Related]
6. IDH1 R132H Mutation Enhances Cell Migration by Activating AKT-mTOR Signaling Pathway, but Sensitizes Cells to 5-FU Treatment as NADPH and GSH Are Reduced.
Zhu H; Zhang Y; Chen J; Qiu J; Huang K; Wu M; Xia C
PLoS One; 2017; 12(1):e0169038. PubMed ID: 28052098
[TBL] [Abstract][Full Text] [Related]
7. IDH1 K224 acetylation promotes colorectal cancer via miR-9-5p/NHE1 axis-mediated regulation of acidic microenvironment.
Wang B; Zhao L; Yang C; Lin Y; Wang S; Ye Y; Luo J; Shen Z
iScience; 2023 Jul; 26(7):107206. PubMed ID: 37456829
[TBL] [Abstract][Full Text] [Related]
8. Functional requirement of a wild-type allele for mutant IDH1 to suppress anchorage-independent growth through redox homeostasis.
Tiburcio PDB; Xiao B; Berg S; Asper S; Lyne S; Zhang Y; Zhu X; Yan H; Huang LE
Acta Neuropathol; 2018 Feb; 135(2):285-298. PubMed ID: 29288440
[TBL] [Abstract][Full Text] [Related]
9. Targeting IDH1-Mutated Malignancies with NRF2 Blockade.
Liu Y; Lu Y; Celiku O; Li A; Wu Q; Zhou Y; Yang C
J Natl Cancer Inst; 2019 Oct; 111(10):1033-1041. PubMed ID: 30759236
[TBL] [Abstract][Full Text] [Related]
10. Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
Wu J; Wang F; Liu X; Zhang T; Liu F; Ge X; Mao Y; Hua D
Eur J Surg Oncol; 2018 Aug; 44(8):1254-1260. PubMed ID: 29871819
[TBL] [Abstract][Full Text] [Related]
11. Isocitrate dehydrogenase 1 mutant R132H sensitizes glioma cells to BCNU-induced oxidative stress and cell death.
Mohrenz IV; Antonietti P; Pusch S; Capper D; Balss J; Voigt S; Weissert S; Mukrowsky A; Frank J; Senft C; Seifert V; von Deimling A; Kögel D
Apoptosis; 2013 Nov; 18(11):1416-1425. PubMed ID: 23801081
[TBL] [Abstract][Full Text] [Related]
12. Silybin suppresses ovarian cancer cell proliferation by inhibiting isocitrate dehydrogenase 1 activity.
Wei Z; Ye S; Feng H; Zeng C; Dong X; Zeng X; Zeng L; Lin X; Liu Q; Yao J
Cancer Sci; 2022 Sep; 113(9):3032-3043. PubMed ID: 35730256
[TBL] [Abstract][Full Text] [Related]
13. Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio.
Itsumi M; Inoue S; Elia AJ; Murakami K; Sasaki M; Lind EF; Brenner D; Harris IS; Chio II; Afzal S; Cairns RA; Cescon DW; Elford AR; Ye J; Lang PA; Li WY; Wakeham A; Duncan GS; Haight J; You-Ten A; Snow B; Yamamoto K; Ohashi PS; Mak TW
Cell Death Differ; 2015 Nov; 22(11):1837-45. PubMed ID: 25882048
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic R132 IDH1 Mutations Limit NADPH for De Novo Lipogenesis through (D)2-Hydroxyglutarate Production in Fibrosarcoma Sells.
Badur MG; Muthusamy T; Parker SJ; Ma S; McBrayer SK; Cordes T; Magana JH; Guan KL; Metallo CM
Cell Rep; 2018 Oct; 25(4):1018-1026.e4. PubMed ID: 30355481
[TBL] [Abstract][Full Text] [Related]
15. Evaluating Mechanisms of IDH1 Regulation through Site-Specific Acetylation Mimics.
Weeks J; Strom AI; Widjaja V; Alexander S; Pucher DK; Sohl CD
Biomolecules; 2021 May; 11(5):. PubMed ID: 34065652
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of IDH1-R132H correlates with poor survival in gastrointestinal cancer.
Li J; Huang J; Huang F; Jin Q; Zhu H; Wang X; Chen M
Oncotarget; 2016 Nov; 7(45):73638-73650. PubMed ID: 27655638
[TBL] [Abstract][Full Text] [Related]
17. IDH1 overexpression induced chemotherapy resistance and IDH1 mutation enhanced chemotherapy sensitivity in Glioma cells in vitro and in vivo.
Wang JB; Dong DF; Wang MD; Gao K
Asian Pac J Cancer Prev; 2014; 15(1):427-32. PubMed ID: 24528069
[TBL] [Abstract][Full Text] [Related]
18. Lack of evidence for substrate channeling or flux between wildtype and mutant isocitrate dehydrogenase to produce the oncometabolite 2-hydroxyglutarate.
Dexter JP; Ward PS; Dasgupta T; Hosios AM; Gunawardena J; Vander Heiden MG
J Biol Chem; 2018 Dec; 293(52):20051-20061. PubMed ID: 30381394
[TBL] [Abstract][Full Text] [Related]
19. Identification and characterization of isocitrate dehydrogenase 1 (IDH1) as a functional target of marine natural product grincamycin B.
Wang Z; Li ZX; Zhao WC; Huang HB; Wang JQ; Zhang H; Lu JY; Wang RN; Li W; Cheng Z; Xu WL; Di Zhu ; Zhou LS; Jiang W; Yu L; Liu JY; Luo C; Zhu H; Dan Ye ; Pan WJ; Ju JH; Dang YJ
Acta Pharmacol Sin; 2021 May; 42(5):801-813. PubMed ID: 32796956
[TBL] [Abstract][Full Text] [Related]
20. Mutant IDH1 Enhances Temozolomide Sensitivity via Regulation of the ATM/CHK2 Pathway in Glioma.
Lin L; Cai J; Tan Z; Meng X; Li R; Li Y; Jiang C
Cancer Res Treat; 2021 Apr; 53(2):367-377. PubMed ID: 33070553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
